Curevin Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.43 M
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
- Satisfied Charges ₹ 1.20 M
- Revenue Growth -82.80%
- Profit Growth -58.84%
- Ebitda -67.12%
- Net Worth -1.37%
- Total Assets -4.99%
About Curevin Pharma
Curevin Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2003 and has a history of 21 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.43 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Chelikani Sandhya, Chelikani Krishna, and Chelikani Harsha serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG2003PTC041002
-
Company No.
041002
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Curevin Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chelikani Krishna
|
Managing Director | 14-May-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Chelikani Sandhya
|
Director | 14-May-2003 | Current |
|
Chelikani Harsha
|
Director | 07-May-2018 | Current |
Financial Performance of Curevin Pharma.
Curevin Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 82.8% decrease. The company also saw a substantial fall in profitability, with a 58.84% decrease in profit. The company's net worth dipped by a decrease of 1.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curevin Pharma?
In 2020, Curevin Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vamsee Overseas Marine Private LimitedChelikani Sandhya and Chelikani Krishna are mutual person
-
Fortune Heights India Private LimitedChelikani Sandhya, Chelikani Krishna and 1 more are mutual person
-
Rs Vaishnavi Infracon Private Limited
Chelikani Sandhya, Chelikani Krishna and 1 more are mutual person
-
-
Smartway Marketing Private Limited
Chelikani Sandhya, Chelikani Krishna and 1 more are mutual person
-
Charges (Loans)
₹2.50 M
₹1.20 M
Charges Breakdown by Lending Institutions
- Indian Bank : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2009 | Indian Bank | ₹2.50 M | Open |
| 11 Jun 2005 | State Bank Of Hyderabad | ₹1.20 M | Satisfied |
How Many Employees Work at Curevin Pharma?
Unlock and access historical data on people associated with Curevin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curevin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curevin Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.